Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
5-Number Summary01:04

5-Number Summary

5.7K
In a dataset, the 5-number summary includes the minimum data value, the data value of the first quartile, the median data value or data value of the second quartile, the data value of the third quartile, and the maximum data value. These 5 data values can be visualized as a box and whisker plot.
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
5.7K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Discharge Summary Forms01:31

Discharge Summary Forms

1.3K
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.3K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

334
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nightmares and insomnia are frequent in patients with functional neurological disorders.

Journal of psychosomatic research·2025
Same author

Qualitative research on the acceptance of evolving evidence for HTA body approval of innovative health technologies in selected European countries.

Expert review of pharmacoeconomics & outcomes research·2025
Same author

Strain- and vaccine-specific effects of serum antibodies in the protection of intestinal SARS-CoV-2 infection.

medRxiv : the preprint server for health sciences·2025
Same author

Restaurants as Environments for Healthy Eating: Factors That Contribute to Restaurant-Based Healthy Eating Program Adoption.

Health promotion practice·2024
Same author

Accurately evaluating for a small bowel obstruction using an abdominal radiograph, by a new method: The Bowel-Spine Ratio.

Radiography (London, England : 1995)·2023
Same author

Evaluating changes to home bowel cancer screening kits: an end-user perspective study.

Cancer causes & control : CCC·2023
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Same journal

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Therapeutic innovation & regulatory science·2026
Same journal

The CARE Program: An Initiative of Patient-Focused Drug Development for Rare Diseases by NMPA.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Feb 11, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Clinical Trial Results Summary for Laypersons: A User Testing Study.

D K Raynor1, L Myers2, K Blackwell3

  • 11 School of Healthcare, University of Leeds, United Kingdom.

Therapeutic Innovation & Regulatory Science
|May 2, 2018
PubMed
Summary
This summary is machine-generated.

User testing improved Clinical Trial Results Laypersons Summaries for readability. This iterative process ensured summaries were accessible and understandable for diverse audiences, meeting new European requirements.

Keywords:
clinical trialhealth literacylay summaryreadabilityuser testing

More Related Videos

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.7K

Related Experiment Videos

Last Updated: Feb 11, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

7.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.7K

Area of Science:

  • Clinical trial communication
  • Health literacy research
  • Regulatory science

Background:

  • European regulations now require Clinical Trial Results Laypersons Summaries.
  • Ensuring these summaries are readable and acceptable to the public is crucial for transparency.
  • Previous methods for assessing summary quality may not adequately reflect layperson comprehension.

Purpose of the Study:

  • To apply user testing to enhance the readability and acceptability of Clinical Trial Results Laypersons Summaries.
  • To iteratively refine summary content and design based on user feedback.
  • To meet new European regulatory requirements for layperson summaries.

Main Methods:

  • Employed "user testing" involving questionnaires and semistructured interviews.
  • Assessed participants' ability to locate and understand key information in the summaries.
  • Conducted multiple testing rounds (Round 1, Round 2, final version) with revisions based on findings.
  • Included participants with varying health literacy levels and a higher education group.
  • Participants accessed summaries on screen.

Main Results:

  • Initial testing identified specific information points (2 of 12) that were not understood or found.
  • User feedback highlighted issues with format, distracting technical explanations, and difficulty understanding study purposes.
  • Subsequent revisions addressed identified problems, though some comprehension challenges persisted (e.g., understanding summary purpose, contextualizing single trial results).
  • Despite challenges, clear and straightforward language was found acceptable by all participants, including those with higher education.

Conclusions:

  • Iterative user testing significantly improved the readability and acceptability of Clinical Trial Results Laypersons Summaries.
  • The process resulted in a summary suitable for individuals across a range of health literacy backgrounds.
  • User testing is an effective method for optimizing patient-facing trial information to meet regulatory and public needs.